The adherence gap
For long-term conditions such as high blood pressure, diabetes, and asthma, much of the work happens at home. The World Health Organization has reported that adherence to long-term therapies in developed countries averages only about 50%, and is lower in low- and middle-income countries [1].
Missed doses and missed reviews can mean poorer control, more complications, and avoidable hospital visits.
What helps
- Clear, plain-language instructions about each medicine.
- Simple routines, and reminders that fit the patient's day.
- Scheduled follow-up appointments so problems are caught early.
- Asking about side effects and cost, which are common reasons people stop.
Follow-up in MediFlow AI
Once a prescription is approved, MediFlow AI can schedule medication reminders and follow-up appointments, and send patient notifications. The aim is to keep patients supported between visits without extra manual work for the care team.
References
- 1.World Health Organization. Adherence to long-term therapies: evidence for action. Geneva: WHO; 2003.
Blog posts share general information and our own perspective. They are not medical advice, and every AI output in MediFlow AI must be reviewed by a licensed clinician.